Cash & equivalents decreased 47.9%
Cash & equivalents changed -47.9% from the comparable as-filed period. The change ranks at the 66th percentile of 120 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -47.9% from the comparable as-filed period. The change ranks at the 66th percentile of 120 prior comparable changes.
Net income changed -2216.8% from the comparable as-filed period. The change ranks at the 100th percentile of 14 prior comparable changes.
Operating income changed -1422.6% from the comparable as-filed period. The change ranks at the 96th percentile of 68 prior comparable changes.
Operating margin changed -10060 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 68 prior comparable changes.
Research & development changed -53.8% from the comparable as-filed period. The change ranks at the 93th percentile of 68 prior comparable changes.
Gross profit changed -10.8% from the comparable as-filed period. The change ranks at the 44th percentile of 27 prior comparable changes.
Revenue changed -10.9% from the comparable as-filed period. The change ranks at the 24th percentile of 68 prior comparable changes.
Gross margin changed +2 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 27 prior comparable changes.
Stock-based compensation changed -1.9% from the comparable as-filed period. The change ranks at the 1th percentile of 68 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.